Hoth Therapeutics Adopts Lantern Pharma's AI Platform for Drug Development

September 04, 2025
Hoth Therapeutics is leveraging Lantern Pharma's PredictBBB.ai platform to enhance drug development, as announced in a press release. The AI tool boasts 94% accuracy in predicting blood-brain barrier permeability.

Hoth Therapeutics is leveraging Lantern Pharma's PredictBBB.ai platform to enhance its drug development processes, announced in a press release. The AI tool, part of Lantern's RADR platform, boasts a 94% accuracy rate in predicting blood-brain barrier permeability, a critical factor in drug candidate success.

By adopting this technology, Hoth aims to streamline candidate selection, reduce development risks, and accelerate timelines for therapeutic discovery. The integration of PredictBBB.ai is expected to provide AI-powered insights that increase precision and reduce uncertainty in drug development, potentially leading to faster regulatory pathways and higher value inflection points for Hoth's pipeline.

Lantern Pharma's CEO, Panna Sharma, expressed enthusiasm for the early adoption of their platform by innovators like Hoth Therapeutics, highlighting the potential of PredictBBB.ai to be a game-changer in central nervous system drug development.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

09/04
Ultrasound AI Secures U.S. Patent for AI-Driven Clinical Value Determination
09/04
Ketryx Secures $39M Series B to Enhance AI Compliance in Life Sciences
09/04
BioLab Holdings Invests in AI Diagnostic Tech with cureVision
09/04
Proprio Adds Rocket Lab CFO Adam Spice to Board
09/04
Reveal HealthTech Secures $7.2M Series A for AI Healthcare Solutions

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like